Healthy Skepticism Library item: 16844

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Report

Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight
The Center for Health & Pharmaceutical Law & Policy 2009 Nov
http://law.shu.edu/ProgramsCenters/HealthTechIP/upload/health_center_whitepaper_nov2009.pdf

Abstract:

Executive Summary
Collaboration among industry, government, and medicine in the pursuit of clinical research
is critical to driving scientific progress, particularly as industry increasingly replaces government as the primary source of research funding. However, the compensation methodologies
employed by industry, as well as other financial relationships between industry and physicians, create potential conflicts of interest that possibly jeopardize the rights and well-being of research participants as well as the integrity of research results.
While the landscape of clinical research has changed dramatically – the number of trials has increased, industry funds a larger proportion of research, and more research now occurs in physicians’ private offices – federal policy on recruitment and enrollment, and conflicts of interest in research more generally, has not changed substantially.
In this White Paper, we make the following recommendations for reform of public policy and industry practice: